Financial implications of RHD genotyping of pregnant women with a serologic weak D phenotype

Publisher： John Wiley & Sons Inc

E-ISSN： 1537-2995|55|9|2095-2103

ISSN： 0041-1132

Source： TRANSFUSION, Vol.55, Iss.9, 2015-09, pp. : 2095-2103

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Financial implications of RHD genotyping of pregnant women with a serologic weak D phenotype

By  

TRANSFUSION, Vol. 41-1132, Iss. 9, 2015-09 ,pp. : 2095-2103

John Wiley & Sons Inc

Access to resources Recommend Favorite

It's time to phase in RHD genotyping for patients with a serologic weak D phenotype

By  

TRANSFUSION, Vol. 55, Iss. 3, 2015-03 ,pp. : 680-689

John Wiley & Sons Inc

Access to resources Recommend Favorite

Noninvasive fetal RHD genotyping of RhD negative pregnant women for targeted anti‐D therapy in Australia: A cost‐effectiveness analysis

By  

PRENATAL DIAGNOSIS, Vol. 37, Iss. 12, 2017-12 ,pp. : 1245-1253

John Wiley & Sons Inc

Access to resources Recommend Favorite

Large-Scale Pre-Diagnosis Study of Fetal RHD Genotyping by PCR on Plasma DNA from RhD-Negative Pregnant Women

By Sciellour C.R-L.  

Molecular Diagnosis, Vol. 8, Iss. 1, 2004-01 ,pp. : 23-31

Adis International

Access to resources Recommend Favorite

A serologic weakly reactive RhD is caused by a RHD 374T>A (Ile125Asn)

By  

TRANSFUSION, Vol. 55, Iss. 6pt2, 2015-06 ,pp. : 1586-1587

John Wiley & Sons Inc

Access to resources Recommend Favorite